Angiogenic Squamous Dysplasia Clinical Trial
Official title:
A Pilot Study of Oral Calcitriol in Patients at High Risk for Lung Cancer
This pilot clinical trial studies the side effects of calcitriol in preventing lung cancer in high risk patients. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of calcitriol may keep cancer from forming in patients with high risk for lung cancer.
PRIMARY OBJECTIVES:
I. To establish the safety of 45 mcg dose of oral calcitriol every other week (QOW) in
non-cancer patients.
OUTLINE:
Patients receive calcitriol orally (PO) QOW on days 1 and 15. Treatment repeats every 28
days for up to 3 months in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up for 30 days.
;
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention